Clearstead Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Clearstead Advisors's CDNA Position: Q2 2026 in Review
Clearstead Advisors opened a new position in CareDx (CDNA) in Q2 2026: 5 shares worth $143. The stake represents ﹤0.01% of the portfolio and ranks #3281 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in CDNA as recently as Q4 2025.
Clearstead Advisors first reported a position in CDNA in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.17K in Q2 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Clearstead Advisors held 5 shares of CareDx worth $143 as of Q2 2026.
- CareDx was a new Clearstead Advisors position in Q2 2026.
- CareDx made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3281 holding.
- Clearstead Advisors first reported a position in CareDx in Q2 2025 and has held it in 4 quarters since.
- Clearstead Advisors's CareDx position peaked at $2.17K in Q2 2025.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.